Scynexis Extendes the Installation of ACD/Labs NMR Processing Tools
News Apr 20, 2006
Advanced Chemistry Development, Inc., (ACD/Labs) has announced that Scynexis, Inc. have expanded their installation of ACD/1D NMR Processor, which eases the interpretation of NMR data through advanced multiplet analysis, verification, and quantitation techniques, at their research facility located in Research Triangle Park, North Carolina.
As a result, average NMR interpretation and dissemination times have been cut dramatically.
This in turn helps speed the drug discovery and development project timelines of their research partners, which is critical in the competitive CRO marketplace.
ACD/1D NMR Processor supports all major NMR formats and brings an array of processing and analysis tools to the scientist’s desktop.
The software is designed to complement the chemist's interpretation workflow and speeds up the process of turning data into the information required to direct a medicinal chemistry program.
Tools like J-Coupler, the multiplet analysis tool, are used to efficiently gather spectral features, which accelerates the preparation of patents and allows chemists to focus on chemistry.
Dr. Darryl LeBlanc, Research Investigator, reflects, "When Scynexis was formed in 2000, we initially had no NMR software other than at the workstations on the instruments."
"Scynexis management’s decision to provide desktop NMR processing and nalysis tools for all our chemists in 2001 resulted in a huge boost in efficiency."
Scynexis scientists utilize ACD/Labs’ extensive databases containing chemical shift values from literature, along with spectral prediction software to facilitate the rapid identification of reaction products and impurities.
Routine NMR data processing tasks are automated via macros to improve speed and consistency in an open-access environment.
These gains are particularly noticeable for chemical libraries, in which NMR spectra for each member is processed identically in minutes.
The flexibility of report formatting in ACD/ChemSketch accommodates the reporting needs of the wide array of projects at Scynexis.
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE